Press Releases
Search
-
13 Nov 2018
bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the Food and Drug Administration (FDA) 510(k) clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel and the CE-Mark of t...
-
09 Nov 2018
bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the ac...
-
18 Oct 2018
Business review for the nine months ended September 30, 2018
Strong sales dynamic confirmed in third quarter, with an 8.8% increase in organic sales Growth of 9.8% at constant exchange rates and scope of consolidation over the nine months ended September 30: €1...
-
25 Sep 2018
bioMérieux commitments in the CDC’s “AMR Challenge”, a joint public-private sector initiative to accelerate the fight against antimicrobial resistance
Marcy l’Étoile (France) – Sept. 25, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, is participating in the AMR Challenge, a new Centers for Disease Control and Prevention (CDC...
-
05 Sep 2018
First-Half 2018 Results
Strong sales dynamic, with sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Contributive operating income before no...
-
18 Jul 2018
Second-Quarter 2018 Business Review
Strong sales dynamic confirmed in second quarter, leading to sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Growt...